Biogen Inc.

BIIB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2009 FY2008
Assets
Cash & Equivalents $581.9M $622.4M
Accounts Receivable $551.2M $446.7M
Inventory $294.0M $263.6M
Total Current Assets $2.48B $2.46B
Property, Plant & Equipment $1.64B $1.59B
Goodwill $1.14B $1.14B
Intangible Assets (Excl. Goodwill) $1.87B $2.16B
Total Assets $8.55B $8.48B
Liabilities
Accounts Payable $118.5M $107.4M
Total Current Liabilities $714.9M $923.2M
Long-Term Debt — —
Total Liabilities $2.29B $2.65B
Stockholders' Equity
Retained Earnings $1.07B $270.2M
Total Stockholders' Equity $6.22B $5.81B
← Newer Page 3 of 3 Older →